Been There, Done That: Eight Decades And Counting By Alice Herb: Reaching 90!
March 8, 2023
By Alice Herb Having just turned 90, I need to reorient myself to who I think I now am. I can’t quite grasp that I have managed to outlive even my mother. She died one day before her 90th birthday- but actually, it was on her birthday, as she…
Brain Boosters: Different Activities To Keep Your Brain In The Game
March 1, 2023
If you’re an avid (or even casual) agebuzz reader, you know that there are many aspects of your lifestyle and habits that maintain and support your aging brain. Whether it’s eating a healthy diet, partaking in regular physical exercise, keeping socially active, or diving into the latest crossword puzzle, it’s…
Busy Minds For Better Brain Health: An Interview With Kristina Lubofsky, Founder of The Busy Minds Box
February 22, 2023
According to the Alzheimer’s Association, more than 6 million Americans currently have Alzheimer’s Disease, with that number projected to rise to nearly 13 million by 2050. For people with Alzheimer’s or other types of cognitive impairment, and for those who care for them, the challenge is to stay active and…
Solitary Confinement: More Bad News About Social Isolation
January 25, 2023
It’s one thing to live alone, as is increasingly the case among older adults in the United States. It’s another to be socially isolated, which the National Institute on Aging describes as “the lack of social contacts and having few people to interact with regularly.” In fact, many older adults…
Lisa Genova, Neuroscientist and New York Times best-selling author of both fiction and non-fiction, including the acclaimed novel “Still Alice.”
January 18, 2023
“Our brains don’t remember everything, but maybe what they remember is enough. And yet even when the meaningful is forgotten, memory doesn’t define what it means to be human.”
Hope In A Bottle: Leqembi, The Newly Approved Alzheimer’s Medication
January 11, 2023
As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…